Neurostimulation of the cholinergic anti-inflammatory pathway ameliorates disease in rat collagen-induced arthritis

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Levine, Yaakov A ^a   Koopman, Frieda A ^b   Faltys, Michael ^a   Caravaca, April ^a   Bendele, Alison ^c   Zitnik, Ralph ^a   Vervoordeldonk, Margriet J ^b,d   Tak, Paul Peter ^b,e,f  

^a Setpoint Medical Corporation   (United States)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c BolderPATH   (United States)

^d Arthrogen BV   (Netherlands)

^e GLAXOSMITHKLINE   (United Kingdom)

^f UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE;

ANIMAL; ARTHRITIS, EXPERIMENTAL; BONE; ELECTRODE; ELECTROSTIMULATION THERAPY; FEMALE; METABOLISM; RAT; VAGUS NERVE;

ACETYLCHOLINE; ANIMALS; ARTHRITIS, EXPERIMENTAL; BONE AND BONES; ELECTRIC STIMULATION THERAPY; ELECTRODES; FEMALE; RATS; VAGUS NERVE;

EID: 84905824890     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104530     Document Type: Article

References (35)

1. Andersson U, Tracey KJ (2012) Reflex principles of immunological homeostasis. Annu Rev Immunol 30: 313-335.
2. Huston JM, Ochani M, Rosas-Ballina M, Liao H, Ochani K, et al. (2006) Splenectomy inactivates the cholinergic antiinflammatory pathway during lethal endotoxemia and polymicrobial sepsis. J Exp Med 203: 1623-1628.
3. Rosas-Ballina M, Olofsson PS, Ochani M, Valdes-Ferrer SI, Levine YA, et al. (2011) Acetylcholine-synthesizing T cells relay neural signals in a vagus nerve circuit. Science 334: 98-101.
4. Borovikova LV, Ivanova S, Zhang M, Yang H, Botchkina GI, et al. (2000) Vagus nerve stimulation attenuates the systemic inflammatory response to endotoxin. Nature 405: 458-462. (Pubitemid 30367422)
5. Van Maanen M, Vervoordeldonk M, Tak P (2009) The cholinergic anti-inflammatory pathway: towards innovative treatment of rheumatoid arthritis. Nat Rev Rheumatol 5: 229-232.
6. van Maanen M, Lebre M, van der Poll T, LaRosa G, Elbaum D, et al. (2009) Stimulation of nicotinic acetylcholine receptors attenuates collagen-induced arthritis in mice. Arthritis Rheum 60: 114-122.
7. van Maanen MA, Stoof SP, Larosa GJ, Vervoordeldonk MJ, Tak PP (2010) Role of the cholinergic nervous system in rheumatoid arthritis: aggravation of arthritis in nicotinic acetylcholine receptor alpha7 subunit gene knockout mice. Ann Rheum Dis 69: 1717-1723.
8. Beekwilder JP, Beems T (2010) Overview of the clinical applications of vagus nerve stimulation. J Clin Neurophysiol 27: 130-138.
9. National Research Council (U.S.). Committee for the Update of the Guide for the Care and Use of Laboratory Animals., Institute for Laboratory Animal Research (U.S.), National Academies Press (U.S.) (2011) Guide for the care and use of laboratory animals. Washington, D.C.: National Academies Press. xxv, 220 p. p.
10. Bendele A, McAbee T, Woodward M, Scherrer J, Collins D, et al. (1998) Effects of interleukin-1 receptor antagonist in a slow-release hylan vehicle on rat type II collagen arthritis. Pharm Res 15: 1557-1561. (Pubitemid 28465742)
11. Bendele AM, Chlipala ES, Scherrer J, Frazier J, Sennello G, et al. (2000) Combination benefit of treatment with the cytokine inhibitors interleukin-1 receptor antagonist and PEGylated soluble tumor necrosis factor receptor type I in animal models of rheumatoid arthritis. Arthritis Rheum 43: 2648-2659. (Pubitemid 32001730)
12. Huston JM, Rosas-Ballina M, Xue X, Dowling O, Ochani K, et al. (2009) Cholinergic neural signals to the spleen down-regulate leukocyte trafficking via CD11b. J Immunol 183: 552-559.
13. de Jonge WJ, van der Zanden EP, The FO, Bijlsma MF, van Westerloo DJ, et al. (2005) Stimulation of the vagus nerve attenuates macrophage activation by activating the Jak2-STAT3 signaling pathway. Nat Immunol 6: 844-851. (Pubitemid 43090471)
14. Saeed R, Varma S, Peng-Nemeroff T (2005) Cholinergic stimulation blocks endothelial cell activation and leukocyte recruitment during inflammation. J Exp Med 201: 1113-1123. (Pubitemid 40524679)
15. Karimi K, Bienenstock J, Wang L, Forsythe P (2010) The vagus nerve modulates CD4+ T cell activity. Brain Behav Immun 24: 316-323.
16. Galitovskiy V, Qian J, Chernyavsky AI, Marchenko S, Gindi V, et al. (2011) Cytokine-Induced Alterations of {alpha}7 Nicotinic Receptor in Colonic CD4 T Cells Mediate Dichotomous Response to Nicotine in Murine Models of Th1/Th17- versus Th2-Mediated Colitis. J Immunol 187: 2677-2687.
17. Ghia JE, Blennerhassett P, Collins SM (2007) Vagus nerve integrity and experimental colitis. Am J Physiol Gastrointest Liver Physiol 293: G560-567. (Pubitemid 47435388)
18. Ghia JE, Blennerhassett P, Kumar-Ondiveeran H, Verdu EF, Collins SM (2006) The vagus nerve: a tonic inhibitory influence associated with inflammatory bowel disease in a murine model. Gastroenterology 131: 1122-1130. (Pubitemid 44498700)
19. Mina-Osorio P, Rosas-Ballina M, Valdes-Ferrer SI, Al-Abed Y, Tracey KJ, et al. (2012) Neural signaling in the spleen controls B-cell responses to blood-borne antigen. Mol Med 18: 618-627.
20. van Maanen M, Stoof S, van der Zanden E, de Jonge W, Janssen R, et al. (2009) The alpha7 nicotinic acetylcholine receptor on fibroblast-like synoviocytes and in synovial tissue from rheumatoid arthritis patients: a possible role for a key neurotransmitter in synovial inflammation. Arthritis Rheum 60: 1272-1281.
21. Waldburger JM, Boyle DL, Pavlov VA, Tracey KJ, Firestein GS (2008) Acetylcholine regulation of synoviocyte cytokine expression by the alpha7 nicotinic receptor. Arthritis Rheum 58: 3439-3449.
22. Zhang P, Han D, Tang T, Zhang X, Dai K (2008) Inhibition of the development of collagen-induced arthritis in Wistar rats through vagus nerve suspension: a 3-month observation. Inflamm Res 57: 322-328.
23. Heck C, Helmers SL, DeGiorgio CM (2002) Vagus nerve stimulation therapy, epilepsy, and device parameters: scientific basis and recommendations for use. Neurology 59: S31-37.
24. Koo B, Ham SD, Sood S, Tarver B (2001) Human vagus nerve electrophysiology: a guide to vagus nerve stimulation parameters. J Clin Neurophysiol 18: 429-433. (Pubitemid 33111568)
25. The Vagus Nerve Stimulation Study Group (1995) A randomized controlled trial of chronic vagus nerve stimulation for treatment of medically intractable seizures. Neurology 45: 224-230.
26. Huston JM, Gallowitsch-Puerta M, Ochani M, Ochani K, Yuan R, et al. (2007) Transcutaneous vagus nerve stimulation reduces serum high mobility group box 1 levels and improves survival in murine sepsis. Crit Care Med 35: 2762-2768. (Pubitemid 350175773)
27. Levine YA, Caravaca A, Faltys M, Arnold A, Zitnik R (2013) Vagus nerve stimulation provides prolonged and spleen-independent protection against indomethacin-induced intestinal inflammation. Gastroenterology 144: S67 (abstract).
28. Lacey DL, Boyle WJ, Simonet WS, Kostenuik PJ, Dougall WC, et al. (2012) Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab. Nat Rev Drug Discov 11: 401-419.
29. Saidenberg-Kermanac'h N, Corrado A, Lemeiter D, deVernejoul MC, Boissier MC, et al. (2004) TNF-alpha antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. Bone 35: 1200-1207. (Pubitemid 39487367)
30. Stolina M, Schett G, Dwyer D, Vonderfecht S, Middleton S, et al. (2009) RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies. Arthritis Res Ther 11: R187.
31. Dore RK, Cohen SB, Lane NE, Palmer W, Shergy W, et al. (2010) Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates. Ann Rheum Dis 69: 872-875.
32. Redlich K, Smolen JS (2012) Inflammatory bone loss: pathogenesis and therapeutic intervention. Nat Rev Drug Discov 11: 234-250.
33. Stolina M, Adamu S, Ominsky M, Dwyer D, Asuncion F, et al. (2005) RANKL is a Marker and Mediator of Local and Systemic Bone Loss in Two Rat Models of Inflammatory Arthritis. Journal of Bone and Mineral Research 20: 1756-1765. (Pubitemid 41361876)
34. Bajayo A, Bar A, Denes A, Bachar M, Kram V, et al. (2012) Skeletal parasympathetic innervation communicates central IL-1 signals regulating bone mass accrual. Proc Natl Acad Sci U S A 109: 15455-15460.
35. Famm K, Litt B, Tracey KJ, Boyden ES, Slaoui M (2013) Drug discovery: a jump-start for electroceuticals. Nature 496: 159-161.